A26T (p.Ala26Thr) variant of MFN2 (Mitofusin-2)
A26T (p.Ala26Thr) in MFN2 (Mitofusin-2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.36 / 1. The record also includes population frequency data and structural context.
A26T (p.Ala26Thr) variant details
- p.Ala26Thr
- rs1362917966
- gnomAD rs1362917966
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.359
- AlphaMissense 0.08
- MetaLR 0.29
- MetaSVM -0.71
- PolyPhen-2 0.03
- SIFT 0.14
- EVE 0.15
- UniProt: Variant assessed as somatic; moderate impact.
- Population evidence available
- Structural context available